Navigation Links
Oral Sex Linked To Mouth Cancer Risk

One of the studies conducted at the Johns Hopkins University monitored 1,670 patients with oral cancer and 1,732 healthy people without the cancer. //They found that the human papilloma virus, which is implicated in the development of oral cancer, was found in a small percentage of the patients who had cancer. It was not found in healthy patients. Among the patients who did have the virus, the HPV16 strain was the most prevalent one. This particular strain has been found to affect one-fifth of women aged between 18 and 25 in some studies in Britain. The Johns Hopkins study found that people whose mouth tumors had the HPV16 strain were three times as likely to have had oral sex as those who did not have the virus.

In a separate study, Swedish researchers at the Malmo University Faculty of Odontology, observed 132 patients with mouth cancer and compared their viral profiles with 320 healthy people. It was found that 36 percent of the cancer patients were harboring the HPV as compared to only 1 percent of the control group. “You should avoid having oral sex,” said the dentist and researcher Kerstin Rosenquist, and lead author of the study at the Malmo University's Faculty of Odontology in southern Sweden. The human papilloma virus is of 40 types and has been associated with genital warts as well as cancer of the cervix or anus and now oral or mouth cancer. Oral cancer is usually caused by smoking, chewing tobacco as well as consuming excess alcohol.
'"/>




Page: 1

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Cough Syrup Ingredient Linked to Stroke
3. Irregular Periods Linked to Diabetes
4. Hormones Linked To Migraines
5. Triglycerides Linked To Stroke Risk
6. Smoking Linked To Low Infant Birth Weight
7. Nausea Linked To Anxiety And Depression
8. Painkiller Linked to Deaths
9. High Levels of Protein Linked to Brain Shrinkage
10. Snoring Linked To Headaches
11. Hormone Therapy Linked to Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , ... benign bony lump located on the forehead usually attributed to a facial fracture. Their ... pain. Dr. Shah has discovered an approach that is minimally invasive. He is an ...
(Date:4/21/2017)... ... 2017 , ... Young Asset Protection, an insurance provider and ... greater Pittsburgh metropolitan region, is joining forces with the local chapter of the ... , Variety the Children’s Charity is a national organization dedicated to empowering, enabling, ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl Institute ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions to ... the award at The Beryl Institute’s annual Patient Experience Conference on March ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry ... O2X , an active lifestyle company that provides Human Performance Training and education ... police offers, first responders, military officers and others in service through the development ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: